Brief: Propanc Biopharma submits orphan drug designation request to FDA for treatment of ovarian cancer

Propanc Biopharma

25/10/2017 13:29

Oct 25 (Reuters) - Propanc Biopharma Inc  PPCB.PK - 
    * Propanc Biopharma submits orphan drug designation request 
to the US Food And Drug Administration for treatment of ovarian 
cancer 
 
Source text for Eikon:  ID:nMKWykCqda  
Further company coverage:  PPCB.PK  
 
 ((Bangalore.newsroom@thomsonreuters.com;))